Jiangxi Rimag Group Co Ltd
HKEX:2522
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (6.2), the stock would be worth HK$15.39 (79% upside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3.4 | HK$8.6 |
0%
|
| 3-Year Average | 6.2 | HK$15.39 |
+79%
|
| 5-Year Average | 6.2 | HK$15.39 |
+79%
|
| Industry Average | 4.4 | HK$10.99 |
+28%
|
| Country Average | 2.8 | HK$6.9 |
-20%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
HK$3.3B
|
/ |
Jan 2026
¥873.1m
|
= |
|
|
HK$3.3B
|
/ |
Dec 2026
¥1.3B
|
= |
|
|
HK$3.3B
|
/ |
Dec 2027
¥1.5B
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Jiangxi Rimag Group Co Ltd
HKEX:2522
|
3.4B HKD | 3.4 | 802.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
105.9B USD | 0.3 | 59.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
72.9B EUR | 0.3 | 14.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
76.6B USD | 0.3 | 12.9 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.2B EUR | 1 | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.4B EUR | 1.1 | 22.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.1B USD | 1.5 | 24.1 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 1.9 | 21.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.5 | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | 11.6 | -27.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 0.8 | 14.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.8 |
| 70th Percentile | 5.4 |
| Max | 5 034 353.9 |
Other Multiples
Jiangxi Rimag Group Co Ltd
Glance View
Jiangxi Rimag Group Co Ltd is a CN-based company operating in Health Care Providers & Services industry. The company is headquartered in Beijing, Beijing and currently employs 1,667 full-time employees. The company went IPO on 2024-06-07. Jiangxi Rimag Group Co Ltd is a China-based company that is primarily engaged in medical imaging specialty medical business. The firm mainly provides medical imaging services and solutions. The firm operates in three segments. Imaging Center Services provide imaging examination and diagnosis services to patients and other healthcare consumers through flagship imaging centers. Imaging Solution Services mainly help hospitals and other medical institution customers select and purchase appropriate imaging equipment to meet their development needs, and provide a series of supporting modular solutions. Rimag Cloud Services provide support for the development of imaging center service business, information management and data-driven operations.
